About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Investor Centre
- Investor Centre
- News & ASX Announcements
Contact

Hit enter to search or ESC to close

Notice of 2015 Annual General Meeting

April 22, 2015

Click here to read more

Post navigation

Appendix 3X Notices – Three New Directors

2014 Annual Report

Related Posts

Phosphagenics Sells BioElixia Beauty Brand to Pure Beauty Australia

August 10, 2017

Terumo Shifts Focus from Oxymorphone Patch to Injectables

March 20, 2018

Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer

January 14, 2015

Recent Posts

Ashland Purchases Manufacturing Rights for VitalET and TPM
June 20, 2019
Change of Company Name and ASX Code
May 24, 2019
2019 Annual General Meeting Results
May 22, 2019

Categories

Analyst Coverage
Company Announcement
Company Report
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- News & ASX Announcements

© Copyright 2019 Avecho Biotechnology Ltd.